New imaging trick may speed up stroke treatment
NCT ID NCT06975696
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a 3D image overlay (fusion imaging) helps doctors reach and remove blood clots in the brain faster during a standard stroke procedure. About 300 adults having emergency clot removal will be randomly assigned to get the extra imaging or not. The goal is to see if fusion imaging leads to more successful and quicker clot removal.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Fusion imaging (3D overlay on live X-ray during clot removal)
- What this could lead to
- If it works, this could make stroke clot removal faster and more successful, potentially improving recovery for many patients.
- What could go wrong
- This is a mid-sized trial testing a technical aid, not a new drug. The benefit may be small or not apply to all patients. No major new risks are expected.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 300 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2026
- Expected to finish
-
May 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Age ≥18 years. 2. Eligible for an EVT procedure Exclusion Criteria: 1. Previous inclusion in this study 2. No access to a preoperative CTA
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute ischemic stroke are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
4 sites in 2 countries. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Helsinki University Central Hospital
NOT_YET_RECRUITINGHelsinki, Finland
-
Skane University Hospital Lund
RECRUITINGLund, 22185, Sweden
-
Turku University Hospital
NOT_YET_RECRUITINGTurku, Finland
-
Örebro University Hospital
NOT_YET_RECRUITINGÖrebro, 70185, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Glenzocimab in anterior stroke with large ischemic core eligible for endovascular therapy
- After stroke, a balloon or a stent? trial tests which rescue opens blocked brain arteries better
- Can a stroke drug shrink brain damage after clot removal?
- AI may forecast stroke outcomes and guide recovery
- A new tool may help stroke survivors get back behind the wheel safely
- Can a new drug boost recovery after stroke surgery?